# NEOANTIGEN VACCINE CLINICAL TRIALS

> **NIH NIH N01** · LEIDOS BIOMEDICAL RESEARCH, INC. · 2020 · $5,794,341

## Abstract

This initiative will demonstrate the feasibility of NCI support for personalized neoantigen vaccine clinical trials.

## Key facts

- **NIH application ID:** 10281326
- **Project number:** 75N91019D00024-0-759102000018-1
- **Recipient organization:** LEIDOS BIOMEDICAL RESEARCH, INC.
- **Principal Investigator:** ETHAN DMITROVSKY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $5,794,341
- **Award type:** —
- **Project period:** 2020-09-25 → 2025-09-24

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10281326

## Citation

> US National Institutes of Health, RePORTER application 10281326, NEOANTIGEN VACCINE CLINICAL TRIALS (75N91019D00024-0-759102000018-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10281326. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*